title: SDZ ASM 981 is the first non-steroid that suppresses established nickel contact dermatitis elicited by allergen challenge.
authors.affiliation: Centre de Pharmacologie Clinique Appliquée à la Dermatologie, France.
authors.forename: C
authors.initials: C
authors.lastname: Queille-Roussel
authors.forename: M
authors.initials: M
authors.lastname: Graeber
authors.forename: M
authors.initials: M
authors.lastname: Thurston
authors.forename: J M
authors.initials: JM
authors.lastname: Lachapelle
authors.forename: J
authors.initials: J
authors.lastname: Decroix
authors.forename: C
authors.initials: C
authors.lastname: de Cuyper
authors.forename: J P
authors.initials: JP
authors.lastname: Ortonne
mesh_terms: D000287:Administration, Topical; D000485:Allergens / Q000009:adverse effects*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D017449:Dermatitis, Allergic Contact / Q000188:drug therapy* / Q000209:etiology; D003879:Dermatologic Agents / Q000627:therapeutic use*; D006801:Humans; D009532:Nickel / Q000009:adverse effects*; D009824:Ointments; D010328:Patch Tests; D012867:Skin / Q000187:drug effects*; D016559:Tacrolimus / Q000031:analogs & derivatives* / Q000627:therapeutic use*
chemical_list: D000485:Allergens; D000894:Anti-Inflammatory Agents, Non-Steroidal; D003879:Dermatologic Agents; D009824:Ointments; C117268:pimecrolimus; D009532:Nickel; D016559:Tacrolimus